Pimentel, Mark

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine

Gastrointestinal motility and disordersGut microbiota and health

Cited by 1,036

ACG Clinical Guideline: Management of Irritable Bowel Syndrome

Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology

Gastrointestinal motility and disordersInfant Health and Development

Cited by 893

Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome

Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 780

Methane, a Gas Produced by Enteric Bacteria, Slows Intestinal Transit and Augments Small Intestinal Contractile Activity

Pimentel, M., Lin, H. C., Enayati, P., van den Burg, B., Lee, H.-R., Chen, J. H., Park, S., Kong, Y., & Conklin, J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 508

The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial

Pimentel, M., Park, S., Mirocha, J., Kane, S. V., & Kong, Y. (2006) · Annals of Internal Medicine

Gastrointestinal motility and disordersGut microbiota and health

Cited by 466

A Systematic Review of Diagnostic Tests for Small Intestinal Bacterial Overgrowth

Khoshini, R., Dai, S.-C., Lezcano, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 323

Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome

Lembo, A., Pimentel, M., Rao, S. S., Schoenfeld, P., Cash, B., Weinstock, L. B., Paterson, C., Bortey, E., & Forbes, W. P. (2016) · Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 310

Methanogens, Methane and Gastrointestinal Motility

Triantafyllou, K., Chang, C., & Pimentel, M. (2014) · Journal of Neurogastroenterology and Motility

Gastrointestinal motility and disordersGut microbiota and health

Cited by 254

Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study

Pimentel, M., Chatterjee, S., Chow, E. J., Park, S., & Kong, Y. (2006) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 160

Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects

Pimentel, M., Morales, W., Rezaie, A., Marsh, E., Lembo, A., Mirocha, J., Leffler, D. A., Marsh, Z., Weitsman, S., Chua, K. S., et al. (2015) · PLOS ONE

Gastrointestinal motility and disordersGut microbiota and health

Cited by 148

Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome

Pimentel, M., Chang, C., Chua, K. S., Mirocha, J., DiBaise, J., Rao, S., & Amichai, M. (2014) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 143

Rifaximin versus Other Antibiotics in the Primary Treatment and Retreatment of Bacterial Overgrowth in IBS

Yang, J., Lee, H.-R., Low, K., Chatterjee, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 129

A Combination of Rifaximin and Neomycin Is Most Effective in Treating Irritable Bowel Syndrome Patients With Methane on Lactulose Breath Test

Low, K., Hwang, L., Hua, J., Zhu, A., Morales, W., & Pimentel, M. (2010) · Journal of Clinical Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 125

Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double‐blind, placebo‐controlled trials

Schoenfeld, P., Pimentel, M., Chang, L., Lembo, A., Chey, W. D., Yu, J., Paterson, C., Bortey, E., & Forbes, W. P. (2014) · Alimentary Pharmacology & Therapeutics

Gastrointestinal motility and disordersGut microbiota and health

Cited by 106

Studying the Overlap Between IBS and GERD: A Systematic Review of the Literature

Nastaskin, I., Mehdikhani, E., Conklin, J., Park, S., & Pimentel, M. (2006) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGastroesophageal reflux and treatments

Cited by 98

Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects

Pimentel, M., Morales, W., Chua, K., Barlow, G., Weitsman, S., Kim, G., Amichai, M. M., Pokkunuri, V., Rook, E., Mathur, R., et al. (2011) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 86

T1390 Rifaximin for the Treatment of Diarrhea-Associated Irritable Bowel Syndrome: Short Term Treatment Leading to Long Term Sustained Response

Lembo, A., Zakko, S. F., Ferreira, N. L., Ringel, Y., Bortey, E., Courtney, K., Corsi, E., Forbes, W. P., & Pimentel, M. (2008) · Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 77

IBS Subjects with Methane on Lactulose Breath Test Have Lower Postprandial Serotonin Levels than Subjects with Hydrogen

Pimentel, M., Kong, Y., & Park, S. (2004) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 68

Visceroptosis of the bowel in the hypermobility type of Ehlers–Danlos syndrome: Presentation of a rare manifestation and review of the literature

Reinstein, E., Pimentel, M., Pariani, M., Nemec, S., Sokol, T., & Rimoin, D. L. (2012) · European Journal of Medical Genetics

Connective tissue disorders researchGastrointestinal motility and disorders

Cited by 47

Proton Pump Inhibitor Therapy Does Not Affect Hydrogen Production on Lactulose Breath Test in Subjects with IBS

Law, D., & Pimentel, M. (2010) · Digestive Diseases and Sciences

Gastrointestinal motility and disordersGut microbiota and health

Cited by 35

Is small intestinal bacterial overgrowth involved in the pathogenesis of functional dyspepsia?

Tziatzios, G., Giamarellos-Bourboulis, E. J., Papanikolaou, I. S., Pimentel, M., Dimitriadis, G. D., & Triantafyllou, K. (2017) · Medical Hypotheses

Gastrointestinal motility and disordersGut microbiota and health

Cited by 30

Small Bowel Culture Confirms the Presence of Small Intestinal Bacterial Overgrowth in a Subset of IBS Subjects

Pyleris, M., Giamarellos-Bourboulis, E. J., Koussoulas, B., Barbatzas, C., & Pimentel, M. (2011) · Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 7

Do antibiotics influence IBS?

Pimentel, M. (2002) · The American Journal of Gastroenterology

Gastrointestinal motility and disordersGut microbiota and health

Cited by 6